Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-09-29 | New | $4,613,213 | $4,613,213 | Equity Only | 06b | SEC link |
| 2023-09-06 | New | $2,438,082 | $2,438,082 | Debt Only | 06b | SEC link |
| 2021-08-20 | New | $8,620,691 | Unknown | Equity Only | SEC link | |
| 2020-09-11 | Amended | $7,414,155 | $5,438,063 | Equity Only | 06b | SEC link |
| 2019-09-17 | New | $1,976,092 | $1,976,092 | Equity Only | 06b | SEC link |
| 2018-04-13 | New | $50,000 | $50,000 | Debt Only | 06b | SEC link |
| Name | Role |
|---|---|
| Thomas Aasen | Director |
| Marc Caron | Director, Executive |
| Elliot Ehrich | Director |
| Jacob Jacobsen | Director, Executive |
| Roger Jeffs | Director |
| John Kaiser | Director |
| Allan Shaw | Director |
| Craig Robert Sincock | Director |
| David Zaccardelli | Director |